Cover Page
Cover Page - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Mar. 25, 2022 | Jun. 30, 2021 | |
Document Information [Line Items] | |||
Entity Registrant Name | Celularity Inc. | ||
Document Type | 10-K/A | ||
Current Fiscal Year End Date | --12-31 | ||
Entity Common Stock, Shares Outstanding | 137,720,526 | ||
Amendment Flag | true | ||
Entity Central Index Key | 0001752828 | ||
Entity Current Reporting Status | Yes | ||
Entity Voluntary Filers | No | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Filer Category | Non-accelerated Filer | ||
Document Period End Date | Dec. 31, 2021 | ||
Document Fiscal Year Focus | 2021 | ||
Document Fiscal Period Focus | FY | ||
Entity Small Business | true | ||
Entity Emerging Growth Company | true | ||
Entity Shell Company | false | ||
Entity Ex Transition Period | false | ||
Document Annual Report | true | ||
Document Transition Report | false | ||
Entity File Number | 001-38914 | ||
Entity Incorporation, State or Country Code | DE | ||
Entity Tax Identification Number | 83-1702591 | ||
Entity Address, Address Line One | 170 Park Ave | ||
Entity Address, City or Town | Florham Park | ||
Entity Address, State or Province | NJ | ||
Entity Address, Postal Zip Code | 07932 | ||
City Area Code | 908 | ||
Local Phone Number | 768-2170 | ||
Entity Interactive Data Current | Yes | ||
Entity Public Float | $ 128.1 | ||
Auditor Firm ID | 34 | ||
Auditor Name | Deloitte & Touche LLP | ||
Auditor Location | Parsippany, New Jersey | ||
Documents Incorporated by Reference [Text Block] | DOCUMENTS INCORPORATED BY REFERENCE None. | ||
Amendment Description | Celularity Inc. is filing this Amendment No. 1 on Form 10-K/A to amend its original Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (the “Original Form 10-K”), originally filed with the Securities and Exchange Commission (the “SEC”) on March 31, 2022, for the sole purpose of filing revised Exhibits 31.1 and 31.2 in order to include in the certifications set forth in the Exhibits the language of revised paragraph 4(b), which language was inadvertently omitted from the certifications when originally filed. This amendment consists solely of the preceding cover page, this explanatory note, Item 8, Item 9A, the list of exhibits filed with this amendment, the signature page and the revised certifications filed as Exhibits 31.1 and 31.2 to this amendment and the required certifications required by the Sarbanes-Oxley Act in connection with the filing of this amendment. Except as described above, this amendment does not reflect events occurring after the date of the filing of the original Annual Report on Form 10-K or modify or update any of the other disclosures contained therein in any way. Accordingly, this amendment should be read in conjunction with the original Annual Report on Form 10-K and Celularity’s other filings with the SEC. This amendment does not reflect events that may have occurred subsequent to the filing of the Original Form. The filing of this amendment is not an admission that the Original Form 10-K, when filed, included any untrue statement of a material fact or omitted to state a material fact necessary to make a statement not misleading. | ||
Common Class A [Member] | |||
Document Information [Line Items] | |||
Title of 12(b) Security | Class A common stock, par value $0.0001 per share | ||
Trading Symbol | CELU | ||
Security Exchange Name | NASDAQ | ||
Warrant [Member] | |||
Document Information [Line Items] | |||
Title of 12(b) Security | Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share | ||
Trading Symbol | CELUW | ||
Security Exchange Name | NASDAQ |